Live Chat

Negocie Bristol Myers BMY

Gráfico BristolMyers ao vivo

Perspectivas

Weekly Search
Weekly
Daily
Data Fechar Mudança Alteração (%): Abertura Max Min

Notícias

Info

Spread

0.33

Spread (%)

0.6312 %

Alavancagem

1:10

Juro overnight, Compra

-0.0597 %

Juro overnight, Venda

-0.0292 %

Moeda

USD

Horários de Negociação

Mercados fechados

Sexta-feira

13:31 - 19:59

Segunda-feira

13:31-19:59

Terça-feira

13:31-19:59

Quarta-feira

13:31-19:59

Quinta-feira

13:31-19:59

Demonstração do resultado

Abertura

---

Fechamento anterior

---

Alta/baixa em 52 semanas

--- – ---

Capitalização de mercado

106397949952

Ações em circulação

2027399936

Data dos rendimentos (Próxima)

2001-08-07

Rendim Divid

2024-11-01

Data Ex-Dividendos

2024-10-04

Taxa anual futura de dividendos

2.4

Rendimento anual futuro de dividendos

0.0449

EPS

-3.25

Ações em circulação

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Saiba mais sobre este instrumento

Ativo
Venda
Comprar
Alteração (%):
Instrumentos relacionados

Markets.com news

Keep up with the news as it happens and know what’s impacting the markets at any time.

Wall Street's leading indices notch fresh records ahead of US inflation data release later today

Quinta-feira, 10 Outubro 2024

Wall St. soars to new highs ahead of US inflation report

Quarta-feira, 9 Outubro 2024

Hang Seng index surges, breaking 21,000 mark

Quarta-feira, 9 Outubro 2024

Dow Jones index today: Dow Hit Record Closing Highs

Quarta-feira, 9 Outubro 2024

Nvidia stock surges 4% in Tuesday, notching its fifth straight day of gains

Live Chat